A Study To Evaluate The Safety And Efficacy Of An Investigational Diabetes Drug In Poorly Controlled Type II Diabetics

NCT00067951 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

190

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: rosiglitazone/metformin

Sponsor

GlaxoSmithKline